Amid all the praise for his raising of FDA's profile and aggressive policy stances, Scott Gottlieb's most valuable contribution while in office may have been leaving the agency fundamentally unchanged, an important lesson for incoming Acting Commissioner Norman Sharpless.
Scott Gottlieb's greatest achievement while commissioner of the US FDA may have been what he chose not to do at the agency.
Since Gottlieb announced his planned departure from FDA, praise has poured in from all corners of the stakeholder community, calling...